Publications

Sort by: Date | Author | Title

Nielsen, N., Wrist Lam, G., Fabrin, K., Holt, P., Thind, P. O. & Jensen, J. B. (2019). Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy. Scandinavian Journal of Urology and Nephrology, 53(4), 213-216. https://doi.org/10.1080/21681805.2019.1624608

Jochumsen, M. R., Bouchelouche, K., Borre, M., Frøkiær, J., Sørensen, J. & Tolbod, L. P. (2019). Repeatability of static 82Rubidium PET for tumor blood flow imaging in prostate cancer - a test-retest study. Poster session presented at Society of Nuclear Medicine and Molecular Imaging: Annual Meeting 2019, Anaheim, California, United States.

Christensen, E., Birkenkamp-Demtröder, K., Sethi, H., Shchegrova, S., Salari, R., Nordentoft, I., Wu, H.-T., Knudsen, M., Lamy, P., Lindskrog, S. V., Taber, A., Balcioglu, M., Vang, S., Assaf, Z., Sharma, S., Tin, A. S., Srinivasan, R., Hafez, D., Reinert, T. ... Dyrskjøt, L. (2019). Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma. Journal of Clinical Oncology, 37(18), 1547-1557. https://doi.org/10.1200/JCO.18.02052

Skriver, C., Dehlendorff, C., Borre, M., Brasso, K., Larsen, S. B., Dalton, S. O., Nørgaard, M., Pottegård, A., Hallas, J., Sørensen, H. T. & Friis, S. (2019). Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study. Annals of Internal Medicine, 170(7), 443-452. https://doi.org/10.7326/M17-3085

Fredsøe, J., Rasmussen, A. K. I., Laursen, E. B., Cai, Y., Howard, K. A., Pedersen, B. G., Borre, M., Mouritzen, P., Òrntoft, T. & Sørensen, K. D. (2019). Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine. Clinical Chemistry, 65(4), 540-548. https://doi.org/10.1373/clinchem.2018.296681

Thomsen, F. B., Jakobsen, H., Langkilde, N. C., Borre, M., Jakobsen, E. B., Frey, A., Lund, L., Lunden, D., Dahl, C., Helgstrand, J. T. & Brasso, K. (2019). Active surveillance for localized prostate cancer. Nationwide, observational study. The Journal of Urology, 201(3), 520-526. https://doi.org/10.1016/j.juro.2018.09.045

Bjerre, M. T., Strand, S. H., Nørgaard, M., Kristensen, H., Rasmussen, A. K., Mortensen, M. M., Fredsøe, J., Mouritzen, P., Ulhøi, B., Ørntoft, T., Borre, M. & Sørensen, K. D. (2019). Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. International Journal of Molecular Sciences , 20(5), Article 1173. https://doi.org/10.3390/ijms20051173

Kjaer, T. K., Andersen, E. A. W., Winther, J. F., Bidstrup, P. E., Borre, M., Møller, H., Larsen, S. B., Johansen, C. & Dalton, S. O. (2019). Long-term Somatic Disease Risk in Adult Danish Cancer Survivors. JAMA Oncology, 5(4), 537-545. https://doi.org/10.1001/jamaoncol.2018.7192

Villumsen, B., Jørgensen, M. G., Frystyk, J., Hordam, B. & Borre, M. (2019). Effectiveness of Unsupervised Home-based Exergaming in Prostate Cancer Patients Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial.

Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Cancer of the Prostate in Sweden (CAPS), Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, The Profile Study, Australian Prostate Cancer BioResource (APCB), The IMPACT Study & Canary PASS Investigators (2019). Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8). Nature Genetics, 51(2), 363. https://doi.org/10.1038/s41588-018-0330-6

Faurschou, I., Ernst , A., Zhao, J., Liao, D. & Olsen, L. H. (2019). The biomechanical properties of the urethra in boys with hypospadias: a preliminary study. Journal of Pediatric Urology, 15(1), 62.e1-62.e7. https://doi.org/10.1016/j.jpurol.2018.09.004

Ernst, A., Brix, N., Lauridsen, L. L. B., Olsen, J., Parner, E. T., Liew, Z., Olsen, L. H. & Ramlau-Hansen, C. H. (2019). Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort. Environmental Health Perspectives, 127(1), Article 17004. https://doi.org/10.1289/EHP3567

Ernst, A., Brix, N., Lauridsen, L. L. B., Olsen, J., Parner, E. T., Liew, Z., Olsen, L. H. & Ramlau-Hansen, C. H. (2019). Acetaminophen (Paracetamol) Exposure During Pregnancy and Pubertal Development in Boys and Girls From a Nationwide Puberty Cohort. American Journal of Epidemiology, 188(1), 34-46. https://doi.org/10.1093/aje/kwy193

Kildegaard, D., Graugaard-Jensen, C., Andersen, K. & Thorlund, J. B. (2019). Danish version of the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) questionnaire: a linguistic translation, cross-cultural adaptation and test-re-test reliability study. Scandinavian Journal of Urology and Nephrology, 53(1), 62-68. https://doi.org/10.1080/21681805.2019.1591501

Vind-Kezunovic, S., Bouchelouche, K., Ipsen, P., Høyer, S., Bell, C. & Bjerggaard Jensen, J. (2019). Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and ¹⁸F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up. European Urology Focus, 5(1), 90-96. https://doi.org/10.1016/j.euf.2017.06.005

Jensen, J. B. (2019). Developments in bladder cancer: Open versus minilaparoscopy versus robot-assisted cystectomy. European Urology Today, 29. Article 71707.

Bjerre, E. D., Brasso, K., Jørgensen, A. B., Petersen, T. H., Eriksen, A. R., Tolver, A., Christensen, J. F., Poulsen, M. H., Madsen, S. S., Østergren, P. B., Borre, M., Krustrup, P., Johansen, C., Rørth, M. & Midtgaard, J. (2019). Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial. Sports Medicine, 49(1), 145-158. https://doi.org/10.1007/s40279-018-1031-0

Jensen, J. B. (2019). Functional urology - Preservation of female sexual function. European Urology Today, 13. Article 71707.

Kristensen, G., Strand, S., Røder, M. A., Berg, K. D., Toft, B. G., Høyer, S., Borre, M., Sørensen, K. D. & Brasso, K. (2019). 5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors. International Journal of Molecular Sciences , 20(5), Article 1025. https://doi.org/10.3390/ijms20051025

Strand, S. H., Bavafaye-Haghighi, E., Kristensen, H., Rasmussen, A. K., Hoyer, S., Borre, M., Mouritzen, P., Besenbacher, S., Orntoft, T. F. & Sorensen, K. D. (2019). A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy. International Journal of Cancer, 145(12), 3445-3452. https://doi.org/10.1002/ijc.32427

Nguyen-Nielsen, M., Møller, H., Tjønneland, A. & Borre, M. (2019). Causes of death in men with prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata). Cancer Epidemiology, 59, 249-257. https://doi.org/10.1016/j.canep.2019.02.017

Bjerre, E. D., Petersen, T. H., Jørgensen, A. B., Johansen, C., Krustrup, P., Langdahl, B., Poulsen, M. H., Madsen, S. S., Østergren, P. B., Borre, M., Rørth, M., Brasso, K. & Midtgaard, J. (2019). Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial. PLOS Medicine, 16(10), Article e1002936. https://doi.org/10.1371/journal.pmed.1002936

Urbschat, A. E., Nielsen, T. K., Nielsen, R. & Maier, T. J. (2019). Effect of nitro fatty acids in LPS challenged primary human renal tubular epithelial cells.

Fisker Vedel, P. & Nielsen, T. K. (2019). Long-term survival of patients treated with laparoscopic cryoablation for small renal tumours. Abstract from NUF 2019, Iceland.

Gopal, M., Peycelon, M., Caldamone, A., Chrzan, R., El-Ghoneimi, A., Olsen, H., Leclair, M. D., Stillebroer, A., MacDonald, C., Tonnhofer, U., Strasser, C., Adam, A., Spinoit, A. F. & Haid, B. (2019). Management of ureteropelvic junction obstruction in children—a roundtable discussion. Journal of Pediatric Urology, 15(4), 322-329. https://doi.org/10.1016/j.jpurol.2019.05.010

Zacho, H. D., Jochumsen, M. R., Langkilde, N.-C., Mortensen, J. C., Haarmark, C., Hendel, H. W., Jensen, J. B. & Petersen, L. J. (2019). No added value of ¹⁸F-sodium fluoride PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer with normal bone scintigraphy. Journal of Nuclear Medicine, 60(12), 1713-1716. https://doi.org/10.2967/jnumed.119.229062

Ernst, A., Lauridsen, L. L. B., Brix, N., Arah, O. A., Olsen, J., Olsen, L. H. & Ramlau-Hansen, C. H. (2019). Parental time to pregnancy, medically assisted reproduction and pubertal development in boys and girls. Human Reproduction, 34(4), 724-732. https://doi.org/10.1093/humrep/dez008

Oedorf, K., Skaaheim Haug, E., Liedberg, F., Järvinen, R., Bjerggaard Jensen, J., Arum, C.-J. R. & Wrist Lam, G. (2019). Perioperative management of radical cystectomy in the Nordic countries. Scandinavian Journal of Urology, 53(1), 51-55. https://doi.org/10.1080/21681805.2019.1583686

Gulley, J. L., Borre, M., Vogelzang, N. J., Ng, S., Agarwal, N., Parker, C. C., Pook, D. W., Rathenborg, P., Flaig, T. W., Carles, J., Saad, F., Shore, N. D., Chen, L., Heery, C. R., Gerritsen, W. R., Priou, F., Langkilde, N. C., Novikov, A. & Kantoff, P. W. (2019). Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology, 37(13), 1051-1061. https://doi.org/10.1200/JCO.18.02031

Malmström, P.-U., Skaaheim Haug, E., Boström, P. J., Gudjónsson, S. & Bjerggaard Jensen, J. (2019). Progress towards a Nordic standard for the investigation of hematuria 2019. Scandinavian Journal of Urology, 53(1), 1-6. https://doi.org/10.1080/21681805.2018.1555187

Sundelin, M. O., Lagerveld, B., Ismail, M., Keeley, F. X. & Nielsen, T. K. (2019). Repeated Cryoablation as Treatment Modality After Failure of Primary Renal Cryoablation: A European Registry for Renal Cryoablation Multinational Analysis. Journal of Endourology, 33(11), 909-913. https://doi.org/10.1089/end.2019.0444

Azawi, N. H., Rohrsted, M., Poulsen, J., Lund, L., Kromann-Andersen, B. & Olsen, L. H. (2019). Robotic versus laparoscopic urological surgery: incidence of reoperation and complications. Scandinavian Journal of Urology, 53(1), 56-61. https://doi.org/10.1080/21681805.2019.1588918

Borre, M. & Jespersen, B. (2019). Sygdomme i nyrer og urinveje. In Sygdomslære Munksgaard .

Jochumsen, M. R., Bouchelouche, K., Borre, M., Frøkiær, J., Sørensen, J. & Tolbod, L. P. (2019). Test-retest study of tumor blood flow quantification with 82Rubidium-PET/CT in prostate cancer. Journal of Nuclear Medicine, 60, Article 1556. http://jnm.snmjournals.org/content/60/supplement_1/1556

Nielsen, M. M., Tolbod, L. P., Borre, M., Høyer, S., Harms, H. J., Sørensen, J., Frøkiær, J. & Borghammer, P. (2019). The relationship between tumor aggressiveness and cholinergic PET imaging in prostate cancer tissue. A proof-of-concept study. American Journal of Nuclear Medicine and Molecular Imaging, 9(3), 185-192.

Schmidt, L., Møller, M., Haldrup, C., Strand, S. H., Vang, S., Hedegaard, J., Høyer, S., Borre, M., Ørntoft, T. & Sørensen, K. D. (2018). Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases. British Journal of Cancer, 119(12), 1527-1537. https://doi.org/10.1038/s41416-018-0321-5

Dadaev, T., Saunders, E. J., Newcombe, P. J., Anokian, E., Leongamornlert, D. A., Brook, M. N., Cieza-Borrella, C., Mijuskovic, M., Wakerell, S., Olama, A. A. A., Schumacher, F. R., Berndt, S. I., Benlloch, S., Ahmed, M., Goh, C., Sheng, X., Zhang, Z., Muir, K., Govindasami, K. ... PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium (2018). Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature Communications, 9(1), Article 2256. https://doi.org/10.1038/s41467-018-04109-8

Christensen, E., Nordentoft, I., Vang, S., Birkenkamp-Demtröder, K., Jensen, J. B., Agerbæk, M., Pedersen, J. S. & Dyrskjøt, L. (2018). Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients. Scientific Reports, 8(1), Article 1917. https://doi.org/10.1038/s41598-018-20282-8

Fredsøe, J., Rasmussen, A. K. I., Thomsen, A. R., Mouritzen, P., Høyer, S., Borre, M., Ørntoft, T. F. & Sørensen, K. D. (2018). Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine. European Urology Focus, 4(6), 825-833. https://doi.org/10.1016/j.euf.2017.02.018

Skøtt, M., Schrøder, H., Hindkjær, J. J. & Kirkeby, H. J. (2018). Sperm preservation by electroejaculation before anticancer therapy. Scandinavian Journal of Urology, 52(5-6), 461-463. https://doi.org/10.1080/21681805.2018.1534883

Rasmussen, L. A., Jensen, H., Virgilsen, L. F., Jensen, J. B. & Vedsted, P. (2018). A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark. Clinical Epidemiology, 10, 1755-1763. https://doi.org/10.2147/CLEP.S177305

Borre, M. (2018). Prostate cancer - screening and early detection. Ugeskrift for Læger, 180(46).

Nørgaard, M., Veres, K., Ording, A. G., Djurhuus, J. C., Jensen, J. B. & Sørensen, H. T. (2018). Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark. JAMA Network Open, 1(7), Article 184909. https://doi.org/10.1001/jamanetworkopen.2018.4909

Birkenkamp-Demtröder, K., Christensen, E., Sethi, H., Sharma, S., Wu, H.-T., Nordentoft, I. K., Taber, A., Vang, S., Lamy, P., Knudsen, M., Salari, R., Shchegrova, S., Lin, C.-H. J., Agerbæk, M., Zimmermann, B., Jensen, J. B. & Dyrskjøt, L. (2018). Serial plasma ctDNA sequencing for early detection of metastatic relapse and monitoring of therapeutic efficacy in Bladder Cancer. Poster session presented at 2nd Annual Research Meeting at the Department of Clinical Medicine, Aarhus, Denmark.

Steffensen, E. H., Cary, C., Jensen, J. B., Larsson, H., Weiner, M. & Nørgaard, M. (2018). Preadmission antidepressant use and bladder cancer a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes. BMC Cancer, 18(1), Article 1035. https://doi.org/10.1186/s12885-018-4939-8

Birkenkamp-Demtröder, K., Christensen, E., Sethi, H., Sharma, S., Wu, H.-T., Taber, A., Agerbæk, M., Zimmermann, B., Lin, C.-H. J., Jensen, J. B. & Dyrskjøt, L. (2018). Longitudinal Assessment of Multiplex Patient-Specific ctDNA Biomarkers in Bladder Cancer for Diagnosis, Surveillance, and Recurrence. viii26-viii27. Abstract from IBCN The International Bladder Cancer Network Annual Meeting 2018, Rotterdam, Netherlands. https://doi.org/10.1093/annonc/mdy269.084

Zacho, H. D., Nielsen, J. B., Afshar-Oromieh, A., Haberkorn, U., deSouza, N., De Paepe, K., Dettmann, K., Langkilde, N. C., Haarmark, C., Fisker, R. V., Arp, D. T., Carl, J., Jensen, J. B. & Petersen, L. J. (2018). Prospective comparison of Ga-PSMA PET/CT, F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 45(11), 1884-1897. https://doi.org/10.1007/s00259-018-4058-4

PLATO collaborators (2018). Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment. Journal of Clinical Oncology, 36(25), 2639-2646. https://doi.org/10.1200/JCO.2018.77.9827

Lelo, A., Prip, F., Harris, B. T., Solomon, D., Berry, D. L., Chaldekas, K., Kumar, A., Simko, J., Jensen, J. B., Bhattacharyya, P., Mannion, C., Kim, J.-S., Philips, G., Dyrskjøt, L. & Waldman, T. (2018). STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer. Clinical Cancer Research, 24(17), 4145-4153. https://doi.org/10.1158/1078-0432.CCR-17-3244

Schmidt, L., Fredsøe, J., Kristensen, H., Strand, S. H., Rasmussen, A., Høyer, S., Borre, M., Mouritzen, P., Ørntoft, T. & Sørensen, K. D. (2018). Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients. Annals of Oncology, 29(9), 2003-2009. https://doi.org/10.1093/annonc/mdy243

Displaying results 551 to 600 out of 1412

Revised 05.11.2025

Johanne Frost Lunding